Clough Capital Partners’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,250
Closed -$237K 140
2021
Q3
$237K Sell
2,250
-65,650
-97% -$9.42M 0.01% 110
2021
Q2
$12M Sell
67,900
-24,510
-27% -$3.94M 0.65% 58
2021
Q1
$12.3M Sell
92,410
-23,130
-20% -$3.58M 0.55% 61
2020
Q4
$15.6M Sell
115,540
-55,680
-33% -$5.67M 1.11% 36
2020
Q3
$14.2M Buy
171,220
+22,300
+15% +$1.79M 1.02% 33
2020
Q2
$12.2M Sell
148,920
-99,300
-40% -$6.72M 1.2% 29
2020
Q1
$12.8M Buy
248,220
+34,920
+16% +$1.82M 1.27% 26
2019
Q4
$8.87M Buy
+213,300
New +$7.87M 0.76% 49

Other funds holding ZLAB

Clough Capital Partners's ZLAB Position: Q4 2021 in Review

Clough Capital Partners sold out of Zai Lab (ZLAB) in Q4 2021, closing a stake of 2,250 shares — an estimated $237K sold.

Clough Capital Partners first reported a position in ZLAB in Q4 2019 and held it in 8 quarters. The position peaked at $15.6M in Q4 2020. 206 funds tracked by Wall St. Rank hold ZLAB as of Q4 2021.

  • Clough Capital Partners reported no remaining Zai Lab position as of Q4 2021 after selling out during the quarter.
  • Clough Capital Partners sold 2,250 Zai Lab shares in Q4 2021, an estimated $237K.
  • Clough Capital Partners first reported a position in Zai Lab in Q4 2019 and held it in 8 quarters.
  • Clough Capital Partners's Zai Lab position peaked at $15.6M in Q4 2020.
  • 206 funds tracked by Wall St. Rank held Zai Lab as of Q4 2021.

Based on Clough Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.